Phase 3 of the Harmonised Clinical Treatment Policy Project

Fallback image

The CCGs across Birmingham and Solihull CCG; Sandwell & West Birmingham CCG, Dudley CCG, Walsall CCG & Wolverhampton CCG are undertaking Phase 3 of the Harmonised Clinical Treatment Policy Project.  This harmonised approach across the footprint of the west midlands is to facilitate consistent, evidence-based policy development for planned patient care.

The remit of the Harmonised Treatment Policy Project is outlined by the Lead Planned Care GP Dr Geoff Naylor:

“Treatment policies are designed to provide fair, consistent, and transparent access to treatment for patients.  CCGs have finite resources and are required to ensure treatment policies are evidence-based, achieve the best clinical outcomes for patients and provide the most cost-effective use of NHS resources.  Our treatment policies have been developed to be informed by the most up to date clinical evidence, best practice and clinical opinion nationally. During this engagement period in Phase 3 treatment policies, we would really value and appreciate feedback from the public to ensure our next phase of treatment policies are as clinically robust as possible for our local patients.”

Between Thursday 5th September and Friday 11th October, the 5 Birmingham and Black Country CCGs will be engaging with clinical colleagues and the public regarding Phase 3a which includes the following 3 DRAFT policies:

  • Subacromial Pain

To view the DRAFT Policy, click here

To view the DRAFT Patient leaflet, click here

To view the Evidence Summary report, click here

To view the Policy Changes Explained, click here.

  • Image-guided therapeutic intra-articular joint injections with corticosteroids with/without local anaesthetic.

To view the DRAFT Policy, click here

To view the DRAFT Patient leaflet, click here

To view the Evidence Summary report, click here

To view the Policy Changes Explained, click here.

  • Image-guided HIGH VOLUME intra-articular injections (40mls+) of saline with or without corticosteroid and/or local anaesthetic

To view the DRAFT Policy, click here

To view the DRAFT Patient Leaflet, click here

To view the Evidence Summary report, click here

To view the Policy Changes Explained, click here.

 

We would be grateful for feedback on the DRAFT Policies, which can be provided to the following email address: agem.treatmentpolicies@nhs.net or via the online questionnaire.

We will also be holding a number of events:

Monday, 23 September

9:00am – 12:30pm

The Savoy Centre, Northfield Road
Netherton, West Midlands,
DY2 9ES

Wednesday, 2 October

1:30pm – 5:00pm

The Workspace, All Saints Road,
Wolverhampton,
WV2 1EL

To register to attend visit: https://www.surveymonkey.co.uk/r/DWWEVENTS